Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,651 | 55,382 | 63,512 | 18,396 | 24,151 |
| TOTAL | $50,341 | $56,138 | $63,970 | $18,841 | $24,506 |
| Non-Current Assets | |||||
| PPE Net | 248 | 345 | 302 | 314 | 278 |
| Other Non-Current Assets | 129 | 52 | 0 | 0 | 0 |
| TOTAL | $377 | $397 | $302 | $314 | $278 |
| Total Assets | $50,718 | $56,535 | $64,272 | $19,155 | $24,784 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 747 | 1,352 | 2,098 | 2,173 | 1,530 |
| Accrued Expenses | 6,938 | 3,727 | 2,258 | 3,478 | 1,893 |
| TOTAL | $7,807 | $5,079 | $4,356 | $5,651 | $3,423 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,807 | $5,079 | $4,356 | $5,651 | $3,423 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 897 | 878 | 871 | 836 | 688 |
| Common Shares | 360 | 351 | 349 | 274 | 274 |
| Retained earnings | -86,145 | -72,118 | -60,957 | -47,552 | -38,960 |
| Other shareholders' equity | -129 | -83 | -83 | 0 | 0 |
| TOTAL | $42,911 | $51,456 | $59,916 | $13,504 | $21,361 |
| Total Liabilities And Equity | $50,718 | $56,535 | $64,272 | $19,155 | $24,784 |